Literature DB >> 17180280

A nontransfusional perioperative management regimen for patients with sickle cell disease undergoing laparoscopic cholecystectomy.

D R Leff1, T Kaura, T Agarwal, S C Davies, J Howard, A C Chang.   

Abstract

BACKGROUND: Patients with sickle cell disease (SCD) are at increased risk for cholelithiasis. Laparoscopic cholecystectomy is the most frequent general surgical operation performed for this group of patients. Acute chest syndrome (ACS) is the most common cause of postoperative death among SCD patients. This study aimed to evaluate the impact of a novel perioperative management regimen involving prophylactic continuous positive airways pressure (CPAP) ventilation and avoidance of preoperative blood transfusion on postoperative SCD-related complications after laparoscopic cholecystectomy.
METHODS: A retrospective study included all SCD patients who underwent laparoscopic cholecystectomy since 1997 at our institution. Medical notes were analyzed to assess the rates of postoperative complications in relation to the severity of SCD.
RESULTS: A total of 13 patients were identified. There were no recorded episodes of acute painful crises and only one patient experienced an episode of ACS requiring protracted CPAP.
CONCLUSION: Laparoscopic cholecystectomy can be safely performed for SCD patients without prior blood transfusion. A defined perioperative regimen including the use of routine postoperative prophylactic CPAP for these patients helps to reduce SCD-related postoperative complications such as ACS and painful vaso-occlusive crises.

Entities:  

Mesh:

Year:  2006        PMID: 17180280     DOI: 10.1007/s00464-006-9054-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   3.453


  21 in total

1.  The pulmonary physician in critical care * Illustrative case 6: Acute chest syndrome of sickle cell anaemia.

Authors:  V Mak; S C Davies
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 2.  Blood transfusion in sickle cell disease.

Authors:  S C Davies; M Roberts-Harewood
Journal:  Blood Rev       Date:  1997-06       Impact factor: 8.250

3.  Severe reactions associated with transfusion of patients with sickle cell disease.

Authors:  G Garratty
Journal:  Transfusion       Date:  1997-04       Impact factor: 3.157

4.  Sickle cell disease and tonsillectomy. Preoperative management and postoperative complications.

Authors:  D J Halvorson; V McKie; K McKie; P E Ashmore; E S Porubsky
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-07

5.  Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.

Authors:  J O Cullis; N Win; J M Dudley; T Kaye
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

6.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

7.  Elective surgery in children with sickle cell disease without preoperative blood transfusion.

Authors:  T C Griffin; G R Buchanan
Journal:  J Pediatr Surg       Date:  1993-05       Impact factor: 2.545

8.  Surgery and anesthesia in sickle cell disease. Cooperative Study of Sickle Cell Diseases.

Authors:  M Koshy; S J Weiner; S T Miller; L A Sleeper; E Vichinsky; A K Brown; Y Khakoo; T R Kinney
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

9.  A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.

Authors:  E P Vichinsky; C M Haberkern; L Neumayr; A N Earles; D Black; M Koshy; C Pegelow; M Abboud; K Ohene-Frempong; R V Iyer
Journal:  N Engl J Med       Date:  1995-07-27       Impact factor: 91.245

10.  Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases.

Authors:  P S Bellet; K A Kalinyak; R Shukla; M J Gelfand; D L Rucknagel
Journal:  N Engl J Med       Date:  1995-09-14       Impact factor: 91.245

View more
  8 in total

1.  Concept of the pathogenesis and treatment of cholelithiasis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Hepatol       Date:  2012-02-27

2.  Low-impact laparoscopic cholecystectomy is associated with decreased postoperative morbidity in patients with sickle cell disease.

Authors:  Nicola de'Angelis; Solafah Abdalla; Maria Clotilde Carra; Vincenzo Lizzi; Aleix Martínez-Pérez; Anoosha Habibi; Pablo Bartolucci; Frédéric Galactéros; Alexis Laurent; Francesco Brunetti
Journal:  Surg Endosc       Date:  2017-11-02       Impact factor: 4.584

3.  Laparoscopic cholecystectomy in 427 adults with sickle cell disease: a single-center experience.

Authors:  Abdulrahman S Al-Mulhim; Abdulmohsen A Al-Mulhim
Journal:  Surg Endosc       Date:  2009-05-15       Impact factor: 4.584

4.  Laparoscopic cholecystectomy in sickle cell patients in Niger.

Authors:  Sani Rachid; Lassey James Didier; Mallam Abdou Badé; Chaibou Maman Sani; Abarchi Habibou
Journal:  Pan Afr Med J       Date:  2009-12-06

5.  Outcomes of inpatients with and without sickle cell disease after high-volume surgical procedures.

Authors:  Michaela A Dinan; Chia-Hung Chou; Bradley G Hammill; Felicia L Graham; Kevin A Schulman; Marilyn J Telen; Shelby D Reed
Journal:  Am J Hematol       Date:  2009-11       Impact factor: 10.047

6.  Blood transfusion in patients with sickle cell disease requiring laparoscopic cholecystectomy.

Authors:  Amr Mostafa Aziz; Abdul-Wahed N Meshikhes
Journal:  JSLS       Date:  2011 Oct-Dec       Impact factor: 2.172

7.  A case series of cholecystectomy in Jamaican sickle cell disease patients - The need for a new strategy.

Authors:  Pierre-Anthony Leake; Marvin Reid; Joseph Plummer
Journal:  Ann Med Surg (Lond)       Date:  2017-02-04

8.  Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trial.

Authors:  Jo Howard; Baba Inusa; Christina Liossi; Eufemia Jacob; Patrick B Murphy; Nicholas Hart; Johanna Gavlak; Sati Sahota; Maria Chorozoglou; Carol Nwosu; Maureen Gwam; Atul Gupta; David C Rees; Swee Lay Thein; Isabel C Reading; Fenella J Kirkham; Man Yeung Edith Cheng
Journal:  Trials       Date:  2015-08-25       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.